A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma

This is a phase II clinical trial investigating the safety and efficacy of intravenous vaccination with mature autologous dendritic cells (DCs) pulsed ex vivo with a liver tumor cell line lysate (HepG2) in patients with advanced hepatocellular carcinoma (HCC). HCC is an attractive target for immunot...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2009-01, Vol.49 (1), p.124-132
Hauptverfasser:	Palmer, Daniel H., Midgley, Rachel S., Mirza, Noweeda, Torr, Elizabeth E., Ahmed, Forhad, Steele, Jane C., Steven, Neil M., Kerr, David J., Young, Lawrence S., Adams, David H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged alpha-Fetoproteins - metabolism Biological and medical sciences Cancer Vaccines - therapeutic use Carcinoma, Hepatocellular - immunology Carcinoma, Hepatocellular - therapy Cell Line, Tumor Dendritic Cells - immunology Female Gastroenterology. Liver. Pancreas. Abdomen Humans Immunotherapy, Adoptive - adverse effects Immunotherapy, Adoptive - methods Liver Neoplasms - therapy Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged Survival Analysis Tumors Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!